NIH-funded research Fellowship grant

Understanding how the cannabinoid cannabichromene is processed in the body

Official title: Investigating the Human Metabolism of the Minor Cannabinoid Cannabichromene

Funded at University of Colorado Denver · NIH-11069331 · Data updated 2026-11-12

This study is looking at how your body processes cannabichromene (CBC), a compound in cannabis that might help with inflammation and mood, to better understand its effects and how it works.

Quick facts

Grant typeFellowship grant
Study typeNIH-funded research
Funding institutionUniversity of Colorado Denver
NIH-funded
Lab location1 site (Aurora, UNITED STATES)
Project startFebruary 1, 2025
Project endJanuary 31, 2028
Funding year2025
Award (this year)$34,518
NIH project number1F31AT013157-01
Project IDNIH-11069331 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals interested in alternative therapies for inflammation or depression, particularly those who may benefit from cannabinoid treatments.

Less likely to help

Patients who do not have interest in or are not affected by inflammatory or depressive conditions may not receive benefit from this research.

What this research studies

This research investigates the metabolism of cannabichromene (CBC), a minor cannabinoid found in cannabis, which has gained popularity for its potential anti-inflammatory and antidepressant effects. The study aims to characterize how CBC is metabolized in the body and to identify the biological activity of its metabolites. By using advanced biochemical techniques, researchers will explore the kinetics of CBC metabolism and its interaction with cytochrome P450 enzymes. This research seeks to fill the knowledge gap regarding the pharmacokinetics of CBC and its therapeutic potential.

Why it matters

Potential benefit: If successful, this research could lead to a better understanding of how cannabichromene can be used therapeutically, particularly for conditions like inflammation and depression.

How similar studies have gone: While there is growing interest in minor cannabinoids, comprehensive studies specifically on cannabichromene's metabolism and effects are still limited, making this research relatively novel.

Where this research is happening

  • University of Colorado Denver
    Aurora, United States
    Active

Researchers

  • Principal investigator: Ward, Alexandra — University of Colorado Denver
  • Study coordinator: Ward, Alexandra

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.